hCG injections and drops for weight loss: FDA status and evidence
No hCG product is FDA approved for weight loss. Prescription hCG has other approved uses, while nonprescription drops, pellets, sprays, and injections marketed for weight loss cannot borrow those approvals; any change during a very-low-calorie diet must not be attributed to hCG without evidence.
No human chorionic gonadotropin (hCG) product is FDA approved for weight loss. Prescription hCG has legitimate approved reproductive uses, but those approvals do not cover weight-loss injections; products sold without a prescription as drops, sprays, pellets, or “homeopathic hCG” have no approved nonprescription weight-loss pathway.14
This is not a claim that hCG has no medical use. It is a product-and-purpose distinction: a drug can be approved for one indication while weight-loss marketing remains unapproved and unsupported.
Separate four products hidden under one name
| Offer | Regulatory question | Evidence question |
|---|---|---|
| Prescription hCG for an approved use | Exact FDA-approved product, label, prescription, and indicated purpose | Does the proposed care match that label and patient context? |
| Prescription hCG injected for weight loss | Off-label weight-loss use; not FDA approved for that purpose | What controlled evidence supports hCG beyond calorie restriction? |
| Compounded hCG | Named compounder, prescription basis, ingredient source, label, beyond-use date, and compounding justification | Why is a compound needed, and what evidence supports the proposed use? |
| OTC drops, sprays, pellets, or “homeopathic” products | No approved OTC hCG weight-loss product | Does the product contain measurable hCG, and are claims substantiated? |
The route does not fix the status. An injection is not approved for weight loss merely because approved hCG drugs are injectable. A drop is not lawful or effective merely because its label says homeopathic. A compounded preparation is not FDA approved and cannot borrow a commercially manufactured product’s approval.5
The calorie prescription is a separate intervention
Many “hCG diet” programs pair the product with roughly 500 calories a day. FDA warns that very-low-calorie diets can create serious risks, including gallstones, electrolyte imbalance, and irregular heartbeat, and should not be reframed as an ordinary wellness plan.1
This creates a basic attribution problem. If weight changes while energy intake is severely restricted, the result cannot be credited to hCG without a comparison showing an effect beyond the diet. A double-blind placebo-controlled trial found no significant hCG advantage for weight, hunger, body circumferences, or related measures under the studied program.3
Testimonials cannot solve that design problem. Neither can a before-and-after image, because calorie intake, water change, other drugs, illness, selection, and follow-up are uncontrolled.
Read an hCG offer as a chain of custody
An offered injection should be traceable from prescriber to dispenser to administered dose. Record:
- prescriber’s name, active license, evaluation, and indicated purpose;
- finished product name, manufacturer or compounding pharmacy, strength, dosage form, and route;
- National Drug Code when applicable, lot, expiration or beyond-use date, and storage;
- pharmacy license and, if claimed, outsourcing-facility status;
- dispensing label and patient information;
- exact diet or program requirements; and
- clinician responsible for adverse effects and follow-up.
A photographed vial is not enough if the lot, label, source, and prescription cannot be matched. “Pharmaceutical grade” and “made in an FDA-registered facility” are not substitutes for an approval or compounding record.
Approved use does not transfer through the molecule
A clinic may show an approved hCG label or FDA database entry. The next question is whether that label’s indication matches weight loss. It does not.1 The same active ingredient can be used in different finished products, doses, routes, and purposes. Approval attaches to the complete product and labeled use.
Off-label prescribing and illegal nonprescription marketing are also not synonyms. FDA explains that clinicians may prescribe approved drugs for unapproved uses when they judge them appropriate, but the use does not become FDA approved.6 That does not validate promotional claims or permit an online seller to market a prescription drug over the counter.
FTC enforcement illustrates the separate advertising standard: health and weight-loss claims need competent, reliable evidence, not testimonials or ingredient narratives.2 FDA and DOJ actions address product and distribution law; FTC actions can address deceptive claims. One agency’s record does not replace the other’s.
“Homeopathic” is not a weight-loss authorization
Some sellers use “homeopathic” to imply that a product sits outside ordinary drug rules. It does not create FDA approval or a special permission to market hCG for weight loss. Some products marketed under the name may contain little or no hCG, which does not make the weight-loss claim supported; it instead raises identity and misbranding questions.
Ask for the complete ingredient list and measured amount per serving. If the seller says the product works through a homeopathic dilution with no pharmacologically measurable hCG, the claim cannot simultaneously rely on hCG’s approved-drug biology as proof of effect.
Program cost should follow clinical accountability
Compare more than the advertised vial or subscription price. A program may bundle evaluation, labs, product, calorie plan, coaching, refills, shipping, membership, body-composition scans, supplements, and cancellation terms. List each component and who is accountable for it.
The weight-loss program cost guide explains how to normalize those units without inventing a local price. For an hCG program, add:
- how the drug or product is sourced and billed;
- whether the diet requires clinical monitoring;
- what symptoms or findings stop the plan;
- what happens if the product is delayed, recalled, or unusable;
- whether follow-up continues after cancellation; and
- whether results claims separate hCG from calorie restriction and other components.
A legitimate consultation welcomes the status question
The provider should be able to say plainly: “This is not FDA approved for weight loss,” then explain the product, rationale, evidence limits, alternatives, monitoring, and consent. Evasive phrases—“FDA-compliant,” “medical grade,” “the hormone is FDA approved,” or “used safely for decades”—do not answer the indication question.
- Name the purpose Write down the exact claimed outcome and separate it from any calorie restriction, coaching, or concurrent medication.
- Identify the product Capture manufacturer or compounder, dosage form, route, strength, lot, expiration or beyond-use date, storage, and dispensing label.
- Match the approval Retrieve the exact approved label and confirm whether the proposed indication appears. Weight loss does not.
- Test the evidence Look for controlled evidence of an hCG effect beyond the diet, with comparable population, dose, outcomes, and follow-up.
- Map accountability Record prescriber, dispenser, monitoring plan, adverse-event contact, cancellation terms, and continuity of care.
Separate the hormone from the diet
Ask: “What evidence shows that this exact hCG product adds a weight-loss benefit beyond the calorie restriction, and where is that purpose approved in its label?” The current FDA answer to the second half is nowhere.
Sources
- U.S. Food and Drug Administration. Avoid dangerous hCG diet products. FDA statement that hCG is not approved for weight loss, has legitimate prescription uses, and is often paired with hazardous very-low-calorie diets. Accessed .
- Federal Trade Commission. FTC charges hCG marketer with deceptive advertising. Federal enforcement illustrating substantiation requirements for hCG weight-loss claims and why testimonials are insufficient. Accessed .
- PubMed. Human chorionic gonadotropin and weight loss: double-blind placebo-controlled trial. Controlled trial finding no hCG advantage over placebo for weight, hunger, circumferences, or related outcomes under the studied regimen. Accessed .
- U.S. Food and Drug Administration. Misbranded hCG products: FDA and DOJ enforcement. Current legal record reinforcing that there is no FDA-approved hCG product for weight loss or nonprescription use. Accessed .
- U.S. Food and Drug Administration. Human drug compounding. FDA framework for compounded drugs, which are not FDA approved and require product- and compounder-specific verification. Accessed .
- U.S. Food and Drug Administration. Understanding unapproved use of approved drugs. FDA explanation of off-label prescribing and why an unapproved use does not become FDA approved. Accessed .